Combination of tagraxofusp and azacitidine is an effective option for relapsed blastic plasmacytoid dendritic cell neoplasm after allogeneic hematopoietic stem cell transplantation
Publication date: Available online 2 March 2021Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Song-Yau Wang, Katrin Thomassen, Lars Kurch, Sabine Opitz, Georg-Nikolaus Franke, Enrica Bach, Uwe Platzbecker, Sabine Kayser
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants